emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университет10.51922/2616-633X.2024.8.1.2168emcardio-51Research ArticleИнтересный клинический случайAn interesting clinical caseПересмотренные клинические рекомендации европейской рабочей группы по диагностике аритмогенной кардиомиопатии (2023)Revised european task force diagnostic criteria for arrhythmogenic cardiomyopathy (2023)КомиссароваС. М.KomissarovaS.

Минск

Minsk

kom_svet@mail.ruРинейскаяН. М.RineiskaN.

Минск

Minsk

ЕфимоваА. А.EfimovaA.

Минск

Minsk

ЧаковаН. Н.ChakovaN.

Минск

Minsk

ГУ «Республиканский научно-практический центр «Кардиология»State Institution Republican Scientific and Practical Centre «Cardiology»ГНУ «Институт генетики и цитологии НАН Беларуси»Institute of Genetics and Cytology of Belarus National Academy of Sciences2024200620258121682180Copyright © Комиссарова С.М., Ринейская Н.М., Ефимова А.А., Чакова Н.Н., 20252025Комиссарова С.М., Ринейская Н.М., Ефимова А.А., Чакова Н.Н.Komissarova S., Rineiska N., Efimova A., Chakova N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/51

   Для улучшения диагностики аритмогенной кардиомиопатии (АКМП) в 2023 г. ведущие европейские эксперты приняли обновленные рекомендации и консенсусный документ с усовершенствованными критериями диагностики АКМП (на основе модифицированных ITF критериев 2010 г. и Падуанских критериев 2020 г.). В представленной статье освещены основные аспекты диагностики и опыт практического применения новых критериев для распознавания различных фенотипов АКМП.

   In order to improve the diagnosis of arrhythmogenic cardiomyopathy (ACM) in 2023, leading European experts validated new recommendations and a consensus report with augmented criteria for diagnosis of ACM (based on modified ITF criteria 2010 and Padua criteria 2020). The article highlights the crucial aspects of diagnosis and practical experience of novel criteria for the recognition of various phenotypes of ACM.

аритмогенная кардиомиопатиякритерии диагностикиобновленные рекомендацииarrhythmogenic cardiomyopathydiagnostic criteriaupdated recommendationsReferencesArbelo E., Protonotarios A., Gimeno J.R., et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J, 2023, vol. 44(37), pp. 3503-3626. doi: 10.1093/eurheartj/ehad194.Arbelo E., Protonotarios A., Gimeno J.R., et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J, 2023, vol. 44(37), pp. 3503-3626. doi: 10.1093/eurheartj/ehad194.Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J, 2010, vol. 31(7), pp. 806-814. doi: 10.1093/eurheartj/ehq025.Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J, 2010, vol. 31(7), pp. 806-814. doi: 10.1093/eurheartj/ehq025.Corrado D., Perazzolo Marra M., Zorzi A., et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol, 2020, vol. 319, pp. 106-114. doi: 10.1016/j.ijcard.2020.06.005.Corrado D., Perazzolo Marra M., Zorzi A., et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol, 2020, vol. 319, pp. 106-114. doi: 10.1016/j.ijcard.2020.06.005.Corrado D., Anastasakis A., Basso C., Bauce B., Blomström-Lundqvist C., et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol, 2024, Jan 15:395:131447. doi: 10.1016/j.ijcard.2023.131447.Corrado D., Anastasakis A., Basso C., Bauce B., Blomström-Lundqvist C., et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report. Int J Cardiol, 2024, Jan 15:395:131447. doi: 10.1016/j.ijcard.2023.131447.Corrado D., van Tintelen P.J., McKenna W.J., et al. International Experts. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414-1429. doi: 10.1093/eurheartj/ehz669.Corrado D., van Tintelen P.J., McKenna W.J., et al. International Experts. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414-1429. doi: 10.1093/eurheartj/ehz669.Richards S., Aziz N., Bale S., et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, vol. 17(5), pp. 405-424. doi: 10.1038/gim.2015.30.Richards S., Aziz N., Bale S., et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, vol. 17(5), pp. 405-424. doi: 10.1038/gim.2015.30.Wang W., Murray B., Tichnell C., Gilotra N.A., Zimmerman S.L., et al. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. Europace, 2022, vol. 24(2), pp. 268-277. doi: 10.1093/europace/euab183.Wang W., Murray B., Tichnell C., Gilotra N.A., Zimmerman S.L., et al. Clinical characteristics and risk stratification of desmoplakin cardiomyopathy. Europace, 2022, vol. 24(2), pp. 268-277. doi: 10.1093/europace/euab183.Verstraelen T.E., van Lint F.H.M., Bosman L.P., de Brouwer R., et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction. Eur Heart J, 2021, vol. 42(29), pp. 2842-2850. doi: 10.1093/eurheartj/ehab294.Verstraelen T.E., van Lint F.H.M., Bosman L.P., de Brouwer R., et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction. Eur Heart J, 2021, vol. 42(29), pp. 2842-2850. doi: 10.1093/eurheartj/ehab294.Corrado D., Zorzi A., Cipriani A., Bauce B., Bariani R., Beffagna G., et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy. J Am Heart Assoc, 2021, vol. 10(18), pp. e021987. doi: 10.1161/JAHA.121.021987.Corrado D., Zorzi A., Cipriani A., Bauce B., Bariani R., Beffagna G., et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy. J Am Heart Assoc, 2021, vol. 10(18), pp. e021987. doi: 10.1161/JAHA.121.021987.

The authors declare that there are no conflicts of interest present.